Filing Flows › Comparisons › AZN vs JNJ
AstraZeneca vs Johnson & Johnson: AZN and JNJ compared
AstraZeneca is the larger company: $30.7B of revenue in its latest quarter (Q2 2026) against $25.4B for Johnson & Johnson (Q3 2026). AstraZeneca is growing faster (+9% against +6% a year earlier). AstraZeneca is more profitable, with an operating margin of 24.2% against 0.1%.
Where the money goes: AZN and JNJ
AstraZeneca (AZN) · Q2 2026
AstraZeneca, Q2 2026: revenue $30.7B (+9% year over year), operating margin 24.2%, net earnings $5.6B. The chart follows the revenue to costs, profit and cash.
Johnson & Johnson (JNJ) · Q3 2026
Johnson & Johnson, Q3 2026: revenue $25.4B (+6% year over year), operating margin 0.1%, net earnings $210M, operating cash flow $7.7B. The chart follows the revenue to costs, profit and cash.
| AstraZeneca (AZN) | Johnson & Johnson (JNJ) | |
|---|---|---|
| Latest quarter | Q2 2026 | Q3 2026 |
| Revenue | $30.7B | $25.4B |
| Revenue growth, Y/Y | +9% | +6% |
| Gross margin | 83.0% | 68.1% |
| Operating margin | 24.2% | 0.1% |
| Net earnings | $5.6B | $210M |
| Net margin | 18.2% | 0.8% |
| Operating cash flow | — | $7.7B |
| Free cash flow | — | $6.4B |
| Market value | — | $676.4B |
| P/E | — | 42.0× |
| Analysts’ mean target | — | $279.41 |
Where the revenue comes from
AstraZeneca
- Oncology: $14.1B (46%)
- BioPharmaceuticals: $11.2B (36%)
- Rare Disease: $4.9B (16%)
- Other Medicines: $486M (2%)
Johnson & Johnson
- Innovative Medicine: $16.8B (66%)
- MEDTECH: $8.6B (34%)
Questions
Which is bigger, AstraZeneca or Johnson & Johnson?
AstraZeneca is the larger company: $30.7B of revenue in its latest quarter (Q2 2026) against $25.4B for Johnson & Johnson (Q3 2026).
Is AstraZeneca or Johnson & Johnson growing faster?
AstraZeneca is growing faster (+9% against +6% a year earlier).
Which is more profitable, AstraZeneca or Johnson & Johnson?
AstraZeneca is more profitable, with an operating margin of 24.2% against 0.1%.
More: AstraZeneca earnings · how AstraZeneca makes money · Johnson & Johnson earnings · how Johnson & Johnson makes money
From the companies' latest 10-Q, 10-K or earnings release (6-K filed Jul 27, 2026; 10-Q filed Oct 21, 2026). Fiscal quarters can end on different dates. Not investment advice.